Companies: 10,795·Total market cap: $144.5T
Bristol-Myers Squibb Company Ce

Bristol-Myers Squibb Company Ce

CELG-RINYSEHealthcare● Active
$0.10
$-0.02(-18.80%)
Market Cap$203798586
P/E Ratio
52W High$0.1229
52W Low$0.0997
Overview

Bristol-Myers Squibb Company Ce(CELG-RI)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · CELG-RI · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2018-122017-122016-122015-122014-12
Revenue
Revenue$15.28B$13.00B$11.23B$9.26B$7.67B
Cost of Revenue$0.59B$0.46B$0.44B$0.42B$0.39B
Gross Profit$14.69B$12.54B$10.79B$8.84B$7.28B
Gross Margin %(computed)96.16%96.45%96.10%95.46%94.97%
Operating Expenses
R&D Expenses$5.67B$5.92B$4.47B$3.70B$2.43B
G&A Expenses$3.25B$2.94B$2.66B$2.31B$2.03B
Total Operating Expenses$8.92B$8.86B$7.13B$6.00B$4.46B
Operating Income$5.19B$4.71B$3.17B$2.25B$2.52B
Operating Margin %(computed)33.97%36.20%28.20%24.36%32.84%
Interest Income$0.00B$0.00B$0.00B$0.00B$0.00B
Interest Expense$0.74B$0.52B$0.50B$0.31B$0.18B
Income Before Tax$4.83B$4.31B$2.37B$2.02B$2.33B
Income Tax Expense$0.79B$1.37B$0.37B$0.42B$0.33B
Net Income$4.05B$2.94B$2.00B$1.60B$2.00B
Net Margin %(computed)26.48%22.61%17.80%17.31%26.07%
Per Share & EBITDA
EPS (Basic)$5.51$3.77$2.57$2.02$2.49
Wtd Avg Shares0.73B0.78B0.78B0.79B0.80B
EBITDA$6.21B$5.31B$3.38B$2.74B$2.88B
EBITDA Margin %(computed)40.63%40.81%30.08%29.63%37.51%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B

深入了解Bristol-Myers Squibb Company Ce

关于Bristol-Myers Squibb Company Ce(CELG-RI)损益表

Bristol-Myers Squibb Company Ce(CELG-RI)损益表数据来源于SEC Form 10-K及10-Q申报文件。2018财年,CELG-RI实现营收$15.28B,毛利润$14.69B(毛利率96.16%),净利润$4.05B(净利率26.48%)。

常见问题

CELG-RI · 4 问

Bristol-Myers Squibb Company Ce(CELG-RI)2018财年营收为$15.28B,同比up17.5%。

CELG-RI revenueCELG-RI salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08